Physician profile
Kunalkumar Kirankumar Vyas
NPI 1235494394
$2,290.95
in general payments reported to CMS, 2019-2025
15 companies · $175 in 2025
The $175 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,506 · 2020: $20.31 · 2021: $40.77 · 2022: $137 · 2023: $368 · 2024: $43.23 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $587.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $586.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $1,402.89 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $163.78 | 2022-2025 | Miebo, Xiidra |
| New World Medical,INC. | $137.91 | 2019-2023 | |
| Rxsight INC | $129.86 | 2023-2024 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Abbvie INC. | $91.41 | 2023 | Xen Glaucoma Treatment System, Botox |
| Alcon Vision LLC | $68.64 | 2019-2025 | Clareon |
| Astellas Pharma US INC | $57.53 | 2023-2025 | Izervay |
| Sight Sciences, INC. | $52.41 | 2021-2023 | Sion Surgical Instrument |
| Glaukos Corporation | $43.09 | 2021-2025 | Idosetr |
| Coherus Oncology, INC. | $37.21 | 2023 | |
| Oyster Point Pharma, INC. | $28.59 | 2025 | Tyrvaya |
| Genentech USA, INC. | $26.19 | 2023 | Vabysmo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $20.31 | 2020 | |
| Ivantis, INC | $17.07 | 2021 | |
| Horizon Therapeutics Plc | $14.06 | 2023 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kunalkumar Vyas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.